Harry Penner Jr., Director at Celldex Therapeutics, Inc. (CLDX), sold 17,728 shares at $24.50 ($434K) on 2013-12-06, disclosed to the SEC on 2013-12-10.
Open-market sale of $434k CLDX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.